ENL
ENL
ENL - Enaleni Pharmaceuticals Announces Change To Board Of Directors
Enaleni Pharmaceuticals Limited
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
JSE code: ENL & ISIN: ZAE000067740
("Enaleni")
Enaleni Pharmaceuticals announces change to Board of Directors
Shareholders are advised as follows:
The Board has appointed Mr Chris Aucamp as Chief Financial Officer with effect
from 1 October 2007. Mr Aucamp, a chartered accountant who has to date been
fulfilling the role of Enaleni Commercial Director, has been the financial
director of Enaleni subsidiary Cipla Medpro for 11 years and has substantial
knowledge of the pharmaceutical industry.
Durban
5 October 2007
Sponsor
Nedbank Capital
Date: 05/10/2007 08:00:07 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
